© 1995 by Biometrika Trust
Estimates of marginal survival for dependent competing risks based on an assumed copula
1Department of Statistics, The Ohio State University Columbus, Ohio 43210, U. S.A
2Department of Biostatistics, The Medical College of Wisconsin 8701 WWatertown Plank Road, Milwaukee, Wisconsin 53226, U.S.A
When time to death and time to censoring are associated one may be appreciably misled when the marginal survival functions are estimated using the product-limit estimators, which assume independent censoring. If no assumption about the relationship between the two times is made, the marginal survival functions are not identifiable. A natural function that defines the association between the two random variables is the copula. We show that if this function is known then the competing risks data are suflScient to identify the marginal survival functions and construct a suitable estimator. This estimator is consistent and reduces to the Kaplan-Meier estimator when death and censoring times are independent. This statistic can be used to provide bounds on the marginal survival functions based on a range of possible associations between the competing risks.
Key Words: Censored data Competing risks Copula Identifiability Survival function
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Zhang and D. F. Heitjan Impact of nonignorable coarsening on Bayesian inference Biostat., October 1, 2007; 8(4): 722 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Grunkemeier, R. Jin, M. J.C. Eijkemans, and J. J.M. Takkenberg Actual and Actuarial Probabilities of Competing Risks: Apples and Lemons Ann. Thorac. Surg., May 1, 2007; 83(5): 1586 - 1592. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Park, L. Tian, and L. J. Wei One- and two-sample nonparametric inference procedures in the presence of a mixture of independent and dependent censoring Biostat., April 1, 2006; 7(2): 252 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang and D. F Heitjan Nonignorable censoring in randomized clinical trials Clinical Trials, December 1, 2005; 2(6): 488 - 496. [Abstract] [PDF] |
||||


